(Reuters) – Drugmaker Merck & Co Inc <MRK.N> reported a drop in third-quarter profit on Tuesday, hit by a $982 million charge related to its acquisition of Peloton Therapeutics.
Net income fell to $1.90 billion (£1.48 billion), or 74 cents per share, from $1.95 billion, or 73 cents per share, a year earlier.
Sales rose to $12.40 billion from $10.79 billion.
(Reporting by Saumya Sibi Joseph and Manas Mishra in Bengaluru; Editing by Anil D’Silva)